Latest news with #AmitSibal
Time of India
7 days ago
- Business
- Time of India
Campus Activewear takes Campus Sutra to court over trademark dispute
Campus Activewear, a prominent Indian sportswear brand, has sued Campus Sutra, a fashion label, over trademark infringement in Delhi High Court. Activewear alleges that Sutra's use of "Campus" could confuse customers and dilute its brand. The buzz around "Campus" is heating up and it's not about student life this time. Campus Activewear, a stalwart in India's sneaker and sportswear scene, has taken Campus Sutra, a trendy fashion label, to the Delhi High Court . The issue? A trademark dispute over the use of the word "Campus," as first highlighted by Bar & Bench. Campus Activewear argues that Campus Sutra's use of 'Campus' even in part of a longer name, risks confusing customers and diluting its strong brand identity. They've asked the court for a permanent ban preventing Sutra from using 'Campus' in any of its products. On the flip side, Campus Sutra, operating under that full name since 2012, says its use of 'Campus' was accidental and extremely limited. From over 11,000 product designs, only three apparently showed up online under 'Campus' alone and Sutra claims those were mistakenly uploaded. The brand has since pulled the listings and promises it won't use the word 'Campus' on its own again, at least until the next court date. Senior Advocate Amit Sibal, representing Sutra, reassured Justice Amit Bansal that the brand has always used the full 'Campus Sutra' label (especially on apparel, not footwear) and that standalone "Campus" usage was unintentional. The court accepted that promise and formally issued a notice to Sutra regarding Activewear's request for interim protection. Both companies are backing their teams with top legal talent: Campus Activewear has Senior Advocate Sandeep Sethi and the Panag & Babu team, while Sutra is defended by Sibal and colleagues. Why does this matter? Beyond the legal clash, it highlights a major tension in Indian retail. Established brands like Campus Activewear see their name, built over decades - as valuable currency, and worry about identity theft in a crowded online marketplace. Brands like Campus Sutra, native to the digital space and targeting younger shoppers, are navigating how far they can push names without stepping on legacy toes. The next court hearing is scheduled for November 10, so stay tuned for what could set a big precedent: how older, offline brands protect their identity in the era of online fashion disruptions or how new-age players carve out space for themselves with creative branding.
Time of India
10-07-2025
- Entertainment
- Time of India
Delhi HC bars Kuku FM from streaming disputed shows in Pocket FM copyright case
The Delhi High Court has barred Kuku FM from releasing new episodes of five series allegedly infringing Pocket FM 's content until the next hearing. The court has also directed Kuku FM to provide full details of the disputed shows. The matter has been adjourned to 29 August. Pocket FM has filed a civil suit against Mebigo Labs , the parent company of Kuku FM, alleging repeated infringement of its intellectual property. The allegations include copyright infringement, passing off of trademarks, unfair trade practices, tortious interference, and inducement to breach contracts. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Senior Living Homes in Sakoli May Surprise You Senior Living | Search Ads Undo The company is seeking damages of Rs 85.7 crore and has requested the appointment of a local commissioner to preserve evidence and investigate the alleged violations. Pocket FM has claimed that Kuku FM has systematically copied its shows over the past four years, despite prior legal actions. It has highlighted alleged infringement of five audio series, Super Yoddha , Insta Empire , Amrapali, Vashikaran, and The Immortal Warrior. Live Events It has also accused Kuku FM of using similar show titles, episode names, and, in one instance, an identical poster for Shoorveer, allegedly designed to mislead listeners and capitalise on Pocket FM's brand reputation. Senior advocate Amit Sibal, appearing for Pocket FM along with law firm Shardul Amarchand Mangaldas, argued that Kuku FM has engaged in 'wholesale infringement' by replicating core creative elements such as themes, characters, and story arcs. In May 2025, Pocket FM filed a separate case in the Delhi High Court against Kuku FM for allegedly pirating its show Insta Millionaire. Sibal told the court that in that case, which resulted in an injunction order on 30 May, Kuku FM had 'bodily lifted' the show. The copying was so blatant, he said, that episodes on Kuku FM's platform ended with the line: 'aage ki kahani jaane ke liye, log in kariye Pocket FM par' (to know the rest of the story, log in to Pocket FM). Calling Kuku FM a 'habitual infringer,' Sibal emphasised the repeated and deliberate nature of the alleged conduct, describing it as 'systematised and extensive'. Pocket FM is seeking a permanent injunction to restrain Kuku FM from using its content, destruction of the infringing material, and an award of damages and legal costs. Pocket FM and Kuku FM are Indian audio streaming platforms that offer spoken-word content such as audiobooks, audio series, and podcasts in multiple Indian languages. Both target regional-language listeners across India and compete in the growing audio content market.
Time of India
24-04-2025
- Health
- Time of India
Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively
In a relief to pharma companies, including Glenmark Pharmaceuticals and Zuventus Healthcare , the Delhi High Court on Thursday held that the government's April 15 notification that prohibited the manufacture, sale, and distribution of all fixed-dose combinations (certain cough syrup brands) for those below four years of age will apply prospectively. The notification issued by the Ministry of Health and Welfare , which came into effect immediately on the said date, mandated a manufacturer to include a warning stating 'fixed-dose combination shall not be used in children below four years of age' on the label and package insert or promotional literature of the drug. A Division Bench led by Chief Justice DK Upadhaya accepted the concerns of the manufacturers that the notification cannot applied retrospectively as some stocks have been manufactured and were in the market before the ban came into effect on April 15. However, the court asked the companies to issue an advisory to doctors, chemists and retailers that fixed dose combination of drugs shall not in 'any circumstances' be prescribed/administered to children below four years of age. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo Additionally, the judges asked the manufacturers to publish an "unambiguously worded notice" in two national newspapers—one in English and one in Hindi— having nationwide circulation. The size of the notices must be designed to attract the attention of readers, the court said. The notice and advisory shall be published within a week, the court said. Live Events However, the manufacturers have been directed to 'compulsorily comply' with the notification by mentioning the warning on all their labels and packaging of all stocks manufactured and circulated after April 15. The pharma companies must file an affidavit furnishing details of the stocks manufactured, sold or have been in circulation before April 15, the court said. However, the court clarified that any such public notice published by the pharma companies should not be construed as an advertisement and would not amount to any breach of their drug license conditions. If the pharma companies abide by the conditions regarding the notice, advisory, and undertakings, irrespective of the manufacture and sale of the drug in question, no coercive measures against them will be taken, the court. The court will hear the case for compliance on May 15. Senior counsel Amit Sibal and counsel Ajay Bhargava alleged that the drug manufacturers and other stakeholders were not given any opportunity of hearing before the notification was issued. The directions came on a couple of appeals filed by Glenmark and Zuventus challenging the validity of the April 15 notification issued by the Department of Health and Welfare that prohibited the use of all formulations of the fixed dose combination of chlorpheniramine maleate plus phenylephrine hydrochloride in children below four years of age. The restrictions issued under Section 26A of the Drugs and Cosmetics Act , 1940 were imposed on the recommendations of the Drugs Technical Advisory, citing safety concerns. The prohibited fixed drug combination is a commonly used formulation found in various over-the-counter drugs used to treat colds and allergies. The drugs, widely prescribed and sold under various brand names, include Ascoril Flu Drops and some variants of Alex by Glenmark Pharma.
